Search Results

This 2-page document provides information on latent TB infection, what a positive TB skin or blood test means, latent TB infection treatment, and various myths and fears about latent TB infection.

This 2-page document provides information on latent TB infection, what a positive TB skin or blood test means, latent TB infection treatment, and various myths and fears about latent TB infection.

This 2-page document provides information on latent TB infection, what a positive TB skin or blood test means, latent TB infection treatment, and various myths and fears about latent TB infection.

The webinar presents information on the common difficulties for TB case management for patients with HIV. The webinar also defines the epidemiologic link between HIV and TB. Additionally, the webinar describes how to incorporate HIV testing and referral to care as part of targeted testing and...

This guide details the latest WHO recommendations, TB diagnostic tools, and how these diagnostic tools should be used in country programs. The guide also provides activists with the information needed to advocate for access to TB diagnostic testing.

In this video, TB survivors talk about the importance of latent TB infection testing and treatment. A TB control professional also describes their experience helping patients with latent TB infection treatment.

The LTBI toolkit was developed by the Pennsylvania Department of Health for primary care physicians who may see patients that are at an increased risk of TB infection.

The kit includes:
-The CDC guidebook, “Latent Tuberculosis Infection: A Guide for Primary Health Providers”
- An article from the...

In this 90-minute webinar, a laboratorian and a clinician from the California Department of Public Health provide information on how to best utilize Xpert MTB/RIF testing. The speakers discuss the manufacturer's rules, share issues in the interpretation of test results, and offer expert opinion on...

This report provides guidance to U.S. public health officials, health-care providers, and laboratory workers for use of FDA-approved IGRAs in the diagnosis of M. tuberculosis infection in adults and children. In brief, TSTs and IGRAs (QFT-G, QFT-GIT, and T-Spot) may be used as aids in diagnosing M...

This new roadmap for 2011-2015 follows on the Global Plan to Stop TB 2006-2015 while setting new and more ambitious targets for the next five years. The action plan, for the first time, identifies all the research gaps that need to be filled to bring rapid TB tests, faster treatment regimens and a...